Log in to search using one of your social media accounts:


1.2million women a year miss cervical cancer screening  

Nearly a third of women ignored smear test invitations last year, figures show. Health bosses urged GPs to provide more convenient appointments in a bid increase uptake.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

International Journal of Cancer, EarlyView.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
CONCLUSIONS: Primary prevention and early detection are key interventions for reducing disparities in cervical cancer incidence and treatment. Community outreach efforts play an important role in reducing inequities in cancer among high-risk groups. The educational intervention utilized in this study was successful in improving knowledge about HPV and cervical cancer. PMID: 29605043 [PubMed - in process]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Tags: Gynecol Oncol Source Type: research
Abstract Screening in women has decreased the incidence and mortality of cervical cancer. Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas are strongly associated with sexually-transmitted high-risk human papillomavirus (HPV) infection, which causes more than 99% of cervical cancers. Screening methods include cytology (Papanicolaou test) and HPV testing, alone or in combination. The American Academy of Family Physicians and the U.S. Preventive Services Task Force recommend starting screening in immunocompetent, asymptomatic women at 21 years of age. Women 21 to 29 years o...
Source: American Family Physician - Category: Primary Care Authors: Tags: Am Fam Physician Source Type: research
Abstract Human papillomavirus infection is the precursor for the development of cervical cancer and is detectable in 99.7% of squamous cell carcinoma and adenocarcinoma cases. Early detection of precancerous lesions with Papanicolaou testing remains the primary mechanism for cancer prevention. Once cervical cancer is diagnosed, treatment may involve surgery, radiation therapy, chemotherapy, or a combination. The choice of therapy depends on the stage of disease, lymph node involvement, patient comorbidities, and risk factors for recurrence. Early-stage, microinvasive disease may be treated with surgery alone if ma...
Source: American Family Physician - Category: Primary Care Authors: Tags: Am Fam Physician Source Type: research
Cancer Science, EarlyView.
Source: Cancer Science - Category: Cancer & Oncology Source Type: research
This article is protected by copyright. All rights reserved. PMID: 29602167 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research
Conclusions: The results show that applying an educational intervention based on PMT might help prevent cervical cancer and improve regular Pap smear testing. PMID: 29582631 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
AbstractBackgroundEthnic minority women are at increased risk of cervical cancer. Self-sampling for high-risk human papillomavirus (HPV) is a promising approach to increase cervical screening among hard-to-reach populations.ObjectiveTo compare a community health worker (CHW)-led HPV self-sampling intervention with standard cervical cancer screening approaches.DesignA 26-week single-blind randomized pragmatic clinical trial.ParticipantsFrom October 6, 2011 to July 7, 2014, a total of 601 Black, Haitian, and Hispanic women aged 30 –65 years in need of cervical cancer screening were recruited, 479 of whom completed...
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
Journal of Women's Health, Ahead of Print.
Source: Journal of Women - Category: OBGYN Authors: Source Type: research
CONCLUSION: The Xpert HPV test is convenient to use on cervical cell samples collected for Pap smear specimens in BD SurePath preservative fluid within an hour and is a viable alternative to the HC2 High-Risk HPV DNA Test for HPV testing. PMID: 29580367 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Tags: J Med Microbiol Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Health | Papanicolaou (Pap) Smear | Women